You are viewing the site in preview mode

Skip to main content

Peer Review reports

From: Efficacy and safety of selinexor-based regimens as first-line treatments for elderly patients with diffuse large B-cell lymphoma: a real-world study

Original Submission
16 Aug 2024 Submitted Original manuscript
2 Apr 2025 Reviewed Reviewer Report
13 Apr 2025 Reviewed Reviewer Report
13 Apr 2025 Reviewed Reviewer Report
27 Apr 2025 Author responded Author comments - Zhiming Li
28 Apr 2025 Reviewed Reviewer Report
1 May 2025 Reviewed Reviewer Report
1 May 2025 Reviewed Reviewer Report
6 May 2025 Author responded Author comments - Zhiming Li
Resubmission - Version 2
27 Apr 2025 Submitted Manuscript version 2
Publishing
8 May 2025 Editorially accepted
15 May 2025 Article published 10.1186/s12885-025-14295-6

You can find further information about peer review here.

Back to article page